BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18(34): 4629-4634 [PMID: 23002331 DOI: 10.3748/wjg.v18.i34.4629] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Vieujean S, Caron B, Haghnejad V, Jouzeau JY, Netter P, Heba AC, Ndiaye NC, Moulin D, Barreto G, Danese S, Peyrin-Biroulet L. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. Int J Mol Sci 2022;23:7611. [PMID: 35886959 DOI: 10.3390/ijms23147611] [Reference Citation Analysis]
2 Moret-Tatay I, Cerrillo E, Hervás D, Iborra M, Sáez-González E, Forment J, Tortosa L, Nos P, Gadea J, Beltrán B. Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications. Clin Transl Gastroenterol 2021;12:e00416. [PMID: 34695034 DOI: 10.14309/ctg.0000000000000416] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Zhang S, Lin S, Tang Q, Yan Z. Knockdown of miR‑205‑5p alleviates the inflammatory response in allergic rhinitis by targeting B‑cell lymphoma 6. Mol Med Rep 2021;24:818. [PMID: 34558634 DOI: 10.3892/mmr.2021.12458] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Alamdari-Palangi V, Vahedi F, Shabaninejad Z, Dokeneheifard S, Movehedpour A, Taheri-Anganeh M, Savardashtaki A. microRNA in inflammatory bowel disease at a glance. Eur J Gastroenterol Hepatol 2021;32:140-8. [PMID: 32558695 DOI: 10.1097/MEG.0000000000001815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo J, Zhang R, Zhao Y, Wang J. MiRNA-29c-3p Promotes Intestinal Inflammation via Targeting Leukemia Inhibitory Factor in Ulcerative Colitis. J Inflamm Res 2021;14:2031-43. [PMID: 34040415 DOI: 10.2147/JIR.S302832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
7 Nijakowski K, Surdacka A. Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review. Int J Mol Sci 2020;21:E7477. [PMID: 33050496 DOI: 10.3390/ijms21207477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
8 Samoilă I, Dinescu S, Costache M. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development-A Focus on Ulcerative Colitis. Cells 2020;9:E1647. [PMID: 32659925 DOI: 10.3390/cells9071647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
9 Guo J, Yang LJ, Sun M, Xu LF. Inhibiting microRNA-7 Expression Exhibited a Protective Effect on Intestinal Mucosal Injury in TNBS-Induced Inflammatory Bowel Disease Animal Model. Inflammation 2019;42:2267-77. [PMID: 31494796 DOI: 10.1007/s10753-019-01091-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Minacapelli CD, Bajpai M, Geng X, Van Gurp J, Poplin E, Amenta PS, Brant SR, Das KM. miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis. Inflamm Bowel Dis 2019;25:78-84. [PMID: 30204869 DOI: 10.1093/ibd/izy279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
11 Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, Quera R, Simian D, Martínez M, Landskron G, Olivares-Morales M, Cidlowski JA, Xu X, Gao G, Xie J, Chnaiderman J, Soto-Rifo R, González MJ, Calixto A, Hermoso MA. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Front Immunol 2019;10:2449. [PMID: 31824476 DOI: 10.3389/fimmu.2019.02449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kubiritova Z, Radvanszky J, Gardlik R. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E3662. [PMID: 31357438 DOI: 10.3390/ijms20153662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
13 Benmoussa A, Provost P. Milk MicroRNAs in Health and Disease. Compr Rev Food Sci Food Saf 2019;18:703-22. [PMID: 33336926 DOI: 10.1111/1541-4337.12424] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
14 Liu Q, Li Y, Ma X, Tang R. Epigenetics of autoimmune liver diseases: current progress and future directions. Journal of Bio-X Research 2019;2:46-55. [DOI: 10.1097/jbr.0000000000000030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, Hart AL, Marchesi JR. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284818822250. [PMID: 30719076 DOI: 10.1177/1756284818822250] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
16 Ng PC, Chan KYY, Yuen TP, Sit T, Lam HS, Leung KT, Wong RPO, Chan LCN, Pang YLI, Cheung HM, Chu WCW, Li K. Plasma miR-1290 Is a Novel and Specific Biomarker for Early Diagnosis of Necrotizing Enterocolitis-Biomarker Discovery with Prospective Cohort Evaluation. J Pediatr 2019;205:83-90.e10. [PMID: 30529132 DOI: 10.1016/j.jpeds.2018.09.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
17 Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, Inoue A, Miyoshi N, Haraguchi N, Takahashi H, Hata T, Matsuda C, Kayama H, Takeda K, Doki Y, Mori M, Yamamoto H. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis. Mol Ther Nucleic Acids 2018;12:658-71. [PMID: 30092402 DOI: 10.1016/j.omtn.2018.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
18 Omidbakhsh A, Saeedi M, Khoshnia M, Marjani A, Hakimi S. Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients. Open Biochem J 2018;12:78-86. [PMID: 30069249 DOI: 10.2174/1874091X01812010078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
19 Wang S, Huang Y, Zhou C, Wu H, Zhao J, Wu L, Zhao M, Zhang F, Liu H. The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease. Gastroenterol Res Pract 2018;2018:7565076. [PMID: 30046303 DOI: 10.1155/2018/7565076] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
20 Li L, Wan G, Han B, Zhang Z. Echinacoside alleviated LPS-induced cell apoptosis and inflammation in rat intestine epithelial cells by inhibiting the mTOR/STAT3 pathway. Biomed Pharmacother 2018;104:622-8. [PMID: 29803175 DOI: 10.1016/j.biopha.2018.05.072] [Cited by in Crossref: 18] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
21 De Iudicibus S, Lucafò M, Vitulo N, Martelossi S, Zimbello R, De Pascale F, Forcato C, Naviglio S, Di Silvestre A, Gerdol M, Stocco G, Valle G, Ventura A, Bramuzzo M, Decorti G. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients. Int J Mol Sci 2018;19:E1399. [PMID: 29738455 DOI: 10.3390/ijms19051399] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
22 Wu W, He Y, Feng X, Ye S, Wang H, Tan W, Yu C, Hu J, Zheng R, Zhou Y. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor. Oncotarget 2017;8:705-21. [PMID: 27893428 DOI: 10.18632/oncotarget.13525] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
23 Gwiggner M, Martinez-Nunez RT, Whiteoak SR, Bondanese VP, Claridge A, Collins JE, Cummings JRF, Sanchez-Elsner T. MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1. Genes (Basel) 2018;9:E85. [PMID: 29438285 DOI: 10.3390/genes9020085] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
24 Liu B, Shi Y, He H, Cai M, Xiao W, Yang X, Chen S, Jia X, Wang J, Lai S. miR-221 modulates skeletal muscle satellite cells proliferation and differentiation. In Vitro Cell Dev Biol Anim 2018;54:147-55. [PMID: 29197032 DOI: 10.1007/s11626-017-0210-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
25 Tao X, Liu S, Men X, Xu Z. Over-expression of miR-146b and its regulatory role in intestinal epithelial cell viability, proliferation, and apoptosis in piglets. Biol Direct 2017;12:27. [PMID: 29178964 DOI: 10.1186/s13062-017-0199-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
26 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
27 Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2017;49:378-87. [PMID: 28077249 DOI: 10.1016/j.dld.2016.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
28 Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, Aloi M, Oliva S, Stronati L. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:315-326. [PMID: 26752466 DOI: 10.1097/MIB.0000000000000659] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
29 Guo J, Jiang X, Gui S. RNA interference-based nanosystems for inflammatory bowel disease therapy. Int J Nanomedicine 2016;11:5287-310. [PMID: 27789943 DOI: 10.2147/IJN.S116902] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
30 Cordes F, Brückner M, Lenz P, Veltman K, Glauben R, Siegmund B, Hengst K, Schmidt MA, Cichon C, Bettenworth D. MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis: . Inflammatory Bowel Diseases 2016;22:2341-55. [DOI: 10.1097/mib.0000000000000917] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
31 Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;15:71. [PMID: 27456681 DOI: 10.1186/s12937-016-0186-5] [Cited by in Crossref: 513] [Cited by in F6Publishing: 666] [Article Influence: 85.5] [Reference Citation Analysis]
32 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
33 Shamran H, Singh NP, Zumbrun EE, Murphy A, Taub DD, Mishra MK, Price RL, Chatterjee S, Nagarkatti M, Nagarkatti PS, Singh UP. Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation. Brain Behav Immun 2017;59:10-20. [PMID: 27327245 DOI: 10.1016/j.bbi.2016.06.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
34 Cosar E, Mamillapalli R, Ersoy GS, Cho S, Seifer B, Taylor HS. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis. Fertil Steril 2016;106:402-9. [PMID: 27179784 DOI: 10.1016/j.fertnstert.2016.04.013] [Cited by in Crossref: 73] [Cited by in F6Publishing: 82] [Article Influence: 12.2] [Reference Citation Analysis]
35 Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
36 Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol 2016;7:160. [PMID: 27199985 DOI: 10.3389/fimmu.2016.00160] [Cited by in Crossref: 214] [Cited by in F6Publishing: 267] [Article Influence: 35.7] [Reference Citation Analysis]
37 Moret-Tatay I, Iborra M, Cerrillo E, Tortosa L, Nos P, Beltrán B. Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel. Oxid Med Cell Longev 2016;2016:2325162. [PMID: 26823944 DOI: 10.1155/2016/2325162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
38 Schaefer JS, Klein JR. Roquin--a multifunctional regulator of immune homeostasis. Genes Immun 2016;17:79-84. [PMID: 26673963 DOI: 10.1038/gene.2015.58] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
39 Krissansen GW, Yang Y, McQueen FM, Leung E, Peek D, Chan YC, Print C, Dalbeth N, Williams M, Fraser AG. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. Inflamm Bowel Dis 2015;21:520-30. [PMID: 25628040 DOI: 10.1097/MIB.0000000000000285] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
40 de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13-27. [PMID: 26627550 DOI: 10.1038/nrgastro.2015.186] [Cited by in Crossref: 722] [Cited by in F6Publishing: 684] [Article Influence: 103.1] [Reference Citation Analysis]
41 Tao X, Men X, Xu Z. Bioinformatic analysis of the ssc-miR-146b upstream promoter region. Anim Nutr 2015;1:368-72. [PMID: 29766997 DOI: 10.1016/j.aninu.2015.12.007] [Reference Citation Analysis]
42 Loddo I, Romano C. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis. Front Immunol. 2015;6:551. [PMID: 26579126 DOI: 10.3389/fimmu.2015.00551] [Cited by in Crossref: 166] [Cited by in F6Publishing: 169] [Article Influence: 23.7] [Reference Citation Analysis]
43 Bai J, Li Y, Shao T, Zhao Z, Wang Y, Wu A, Chen H, Li S, Jiang C, Xu J, Li X. Integrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer. Mol Biosyst 2014;10:2317-28. [PMID: 24949825 DOI: 10.1039/c4mb00169a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
44 Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS. Circulating microRNAs as biomarkers of adult Crohn’s disease: . European Journal of Gastroenterology & Hepatology 2015;27:1038-44. [DOI: 10.1097/meg.0000000000000430] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
45 Ng PC, Chan KY, Leung KT, Tam YH, Ma TP, Lam HS, Cheung HM, Lee KH, To KF, Li K. Comparative MiRNA Expressional Profiles and Molecular Networks in Human Small Bowel Tissues of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation. PLoS One 2015;10:e0135737. [PMID: 26274503 DOI: 10.1371/journal.pone.0135737] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
46 Wu F, Dong F, Arendovich N, Zhang J, Huang Y, Kwon JH. Divergent influence of microRNA-21 deletion on murine colitis phenotypes. Inflamm Bowel Dis 2014;20:1972-85. [PMID: 25222661 DOI: 10.1097/MIB.0000000000000201] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
47 Däbritz J, Menheniott TR. Linking immunity, epigenetics, and cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1638-1654. [PMID: 24896241 DOI: 10.1097/mib.0000000000000063] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
48 Cheng X, Zhang X, Su J, Zhang Y, Zhou W, Zhou J, Wang C, Liang H, Chen X, Shi R, Zen K, Zhang CY, Zhang H. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease. Sci Rep. 2015;5:10397. [PMID: 25997679 DOI: 10.1038/srep10397] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
49 Pathak S, Grillo AR, Scarpa M, Brun P, D’Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med. 2015;47:e164. [PMID: 25998827 DOI: 10.1038/emm.2015.21] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
50 Jiang W, Li X. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Mol Diagn Ther 2015;19:141-58. [DOI: 10.1007/s40291-015-0142-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
51 Mirza AH, Berthelsen CH, Seemann SE, Pan X, Frederiksen KS, Vilien M, Gorodkin J, Pociot F. Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med. 2015;7:39. [PMID: 25991924 DOI: 10.1186/s13073-015-0162-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 108] [Article Influence: 13.9] [Reference Citation Analysis]
52 Nothnick WB, Al-Hendy A, Lue JR. Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise. J Minim Invasive Gynecol 2015;22:719-26. [PMID: 25757811 DOI: 10.1016/j.jmig.2015.02.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
53 Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR. MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis. BMC Immunol. 2015;16:5. [PMID: 25886994 DOI: 10.1186/s12865-015-0069-0] [Cited by in Crossref: 88] [Cited by in F6Publishing: 101] [Article Influence: 12.6] [Reference Citation Analysis]
54 Van der Goten J, Vanhove W, Lemaire K, Van Lommel L, Machiels K, Wollants WJ, De Preter V, De Hertogh G, Ferrante M, Van Assche G. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis. PLoS One. 2014;9:e116117. [PMID: 25546151 DOI: 10.1371/journal.pone.0116117] [Cited by in Crossref: 38] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
55 Stachurska A, Zorro MM, van der Sijde MR, Withoff S. Small and Long Regulatory RNAs in the Immune System and Immune Diseases. Front Immunol 2014;5:513. [PMID: 25368617 DOI: 10.3389/fimmu.2014.00513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
56 Nijhuis A, Biancheri P, Lewis A, Bishop CL, Giuffrida P, Chan C, Feakins R, Poulsom R, Di Sabatino A, Corazza GR. In Crohn’s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Clin Sci (Lond). 2014;127:341-350. [PMID: 24641356 DOI: 10.1042/cs20140048] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
57 Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 2014; 5(2): 63-70 [PMID: 24891977 DOI: 10.4291/wjgp.v5.i2.63] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
58 Ganepola GA, Nizin J, Rutledge JR, Chang DH. Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol 2014; 6(4): 83-97 [PMID: 24734154 DOI: 10.4251/wjgo.v6.i4.83] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
59 Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol 2014; 20(12): 3255-3264 [PMID: 24695798 DOI: 10.3748/wjg.v20.i12.3255] [Cited by in CrossRef: 129] [Cited by in F6Publishing: 118] [Article Influence: 16.1] [Reference Citation Analysis]
60 Zhang XH, Zhang YN, Liu Z. MicroRNA in chronic rhinosinusitis and allergic rhinitis. Curr Allergy Asthma Rep 2014;14:415. [PMID: 24408538 DOI: 10.1007/s11882-013-0415-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
61 Iudicibus SD, Lucafò M, Martelossi S, Pierobon C, Ventura A, Decorti G. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. World J Gastroenterol 2013; 19(44): 7947-7954 [PMID: 24307788 DOI: 10.3748/wjg.v19.i44.7947] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
62 Bjerrum JT, Nyberg C, Olsen J, Nielsen OH. Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease. J Intern Med 2014;275:484-93. [PMID: 24206446 DOI: 10.1111/joim.12160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
63 Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol. 2013;173:250-258. [PMID: 23607522 DOI: 10.1111/cei.12104] [Cited by in Crossref: 79] [Cited by in F6Publishing: 89] [Article Influence: 8.8] [Reference Citation Analysis]
64 Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, Nielsen OH. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol 2013; 19(27): 4289-4299 [PMID: 23885139 DOI: 10.3748/wjg.v19.i27.4289] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
65 Chen Y, Wang C, Liu Y, Tang L, Zheng M, Xu C, Song J, Meng X. miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn’s disease. Biochem Biophys Res Commun. 2013;438:133-139. [PMID: 23872065 DOI: 10.1016/j.bbrc.2013.07.040] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]